A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR (BKM120)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01570296
Recruitment Status : Active, not recruiting
First Posted : April 4, 2012
Last Update Posted : August 22, 2018
Information provided by (Responsible Party):
National Cancer Centre, Singapore

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : February 22, 2016
  Estimated Study Completion Date : April 2019